contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


aqua-bio-technology-asa-new-share-capital-registered-9

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Aqua Bio Technology is a Norwegian company operating in the cosmetics industry. The company develops, manufactures and commercializes ingredients that are used in various cosmetic products worldwide. The largest business is in solutions for skin care products. Most of the company's products are sold on a global market through various distributors. The company was founded in 2004 and has its headquarters in Lysaker.

Aqua Bio Technology

Reference is made to the private placement of 48,432,000 new shares in Aqua Bio Technology ASA (the "Company") placed in March 2025 (the "Private Placement") and to the subsequent offering carried...

<div class="mfn-body">Reference is made to the private placement of 48,432,000 new shares in Aqua Bio Technology ASA (the "Company") placed in March 2025 (the "Private Placement") and to the subsequent offering carried out in March and April 2025 (the "Subsequent Offering"), where a total of 4,111,975 new shares were allocated (together with the new shares in the Private Placement, the "New Shares"). Reference is further made to the resolution by an extraordinary general meeting on 25 July 2025 to increase the Company's share capital in connection with the Private Placement and the Subsequent Offering, and furthermore to the resolution by an extraordinary general meeting on 7 November 2025 to reduce the Company's share capital by reduction of the par value of the Company's shares to NOK 0.10 per share (the "Share Capital Decrease"). &nbsp; Through the Private Placement, the Company has issued 48,432,000 New Shares at a subscription price of NOK 0.50 per New Share, each with a par value of NOK 0.10. Consequently, the share capital of the Company was increased with NOK 4,843,200 through the Private Placement. &nbsp; Through the Subsequent Offering, the Company has issued 4,111,975 New Shares at a subscription price of NOK 0.50 per New Shares, each with a par value of NOK 0.10. Consequently, the share capital of the Company was increased with NOK 411,197.50 through the Subsequent Offering. &nbsp; Through the Share Capital Decrease, the Company's share capital was decreased with NOK 261,246,580.80, through reduction of the par value of the Company's shares from NOK 2.50 to NOK 0.10 per share. &nbsp; Following registration of the share capital changes described above, the Company's new share capital is NOK 16,139,671.70 divided by 161,396,717 shares, each with a par value of NOK 0.10. &nbsp; The New Shares will initially be registered with the VPS and delivered to the subscribers in the Private Placement and the Subsequent Offering on a separate, non-tradable ISIN, pending approval and publication of a listing prospectus. Such listing prospectus is currently expected to be approved and published by end of December 2025.</div><div class="mfn-footer mfn-contacts mfn-76be5d61d270">Contacts Kristian Flaten CEO &amp; CFO Aqua Bio Technology ASAPhone: +47 9509 2322 Email: <a rel="noopener" href="mailto:kf@aquabiotech.no">kf@aquabiotech.no</a></div><div class="mfn-footer mfn-about mfn-4705b2e2e705">About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.This notice is published by Kristian Flaten on the listed date and time. </div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar-nsta">This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication at 2025-11-11 15:00 CET.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments <a rel="noopener" href="https://storage.mfn.se/531a1f3d-0f90-4172-8184-cdc46d079f4a/aqua-bio-technology-asa-new-share-capital-registered.pdf" class="mfn-generated mfn-primary">Aqua Bio Technology ASA: New share capital registered</a></div>